Skip to Content
Merck

B4559

BRL 44408 maleate salt

≥98% (HPLC)

Synonym(s):

2-[2H-(1-Methyl-1,3-dihydroisoindole)methyl]-4,5-dihydroimidazole maleate salt

Sign In to View Organizational & Contract Pricing.

Select a Size

All Photos(2)

About This Item

Empirical Formula (Hill Notation):
C17H21N3O4
CAS Number:
118343-19-4
Molecular Weight:
331.37
NACRES:
NA.77
PubChem Substance ID:
329773239
UNSPSC Code:
12352200
MDL number:
MFCD02262218

Product Name

BRL 44408 maleate salt, ≥98% (HPLC)

InChI key

DDIQGSUEJOOQQQ-BTJKTKAUSA-N

SMILES string

OC(=O)\C=C/C(O)=O.CC1N(CC2=NCCN2)Cc3ccccc13

InChI

1S/C13H17N3.C4H4O4/c1-10-12-5-3-2-4-11(12)8-16(10)9-13-14-6-7-15-13;5-3(6)1-2-4(7)8/h2-5,10H,6-9H2,1H3,(H,14,15);1-2H,(H,5,6)(H,7,8)/b;2-1-

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

H2O: soluble 15 mg/mL, clear

originator

GlaxoSmithKline

Quality Level

100

Biochem/physiol Actions

BRL 44408 maleate is a selective α2A-adrenoceptor antagonist.

Features and Benefits

This compound is featured on the α2-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Legal Information

Sold under agreement from Glaxo­Smith­Kline

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000408980
0000408980
0000140392
0000140389
0000125366

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Roberto T Sudo et al.
The journal of pain : official journal of the American Pain Society, 11(1), 71-78 (2009-10-27)
Finding new chemicals or adjuvants with analgesic effects in the central nervous system is clinically relevant due to the limited number of drugs with these properties. Here, we present PT-31, which is chemically related to 3-benzyl-imidazolidine, with an analgesic profile
Zoltán S Zádori et al.
Neurochemistry international, 51(5), 297-305 (2007-08-01)
The inhibitory effect of clonidine (non-selective alpha2-adrenoceptor agonist) and oxymetazoline (alpha2A-adrenoceptor selective agonist) was compared on basal and stimulated gastric motor activity (gastric tone and contractions) using the balloon method in the rat. It was shown that oxymetazoline (0.2-1.7 micromol/kg
Baogang Liu et al.
Neuroreport, 17(12), 1313-1317 (2006-09-05)
Perineural injection of clonidine at the site of nerve injury reduces hypersensitivity while simultaneously reducing leukocyte number and cytokine expression and hyperexcitability in sensory neurons. The activation of p38 mitogen-activated protein kinase in sensory neurons contributes to the development and
Alfonso Romero-Sandoval et al.
Anesthesiology, 104(2), 351-355 (2006-01-27)
Partial sciatic nerve ligation (PSNL) produces axonal damage, a local inflammatory response, and wallerian degeneration. Cytokines secreted near the site of nerve injury are thought to play important roles in development and maintenance of central sensitization and neuropathic pain. Injection
Bruce Posner et al.
Analytical biochemistry, 365(2), 266-273 (2007-04-27)
Multiplexing of G protein-coupled receptors (GPCRs) in microarrays promises to increase the efficiency, reduce the costs, and improve the quality of high-throughput assays. However, this technology is still nascent and has not yet achieved the status of "high throughput" or
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service